{"id":1057,"date":"2026-06-03T09:23:25","date_gmt":"2026-06-03T09:23:25","guid":{"rendered":"http:\/\/bcregmed.co.uk\/?p=1057"},"modified":"2026-06-03T09:23:29","modified_gmt":"2026-06-03T09:23:29","slug":"ace-retino-clinical-trial-paediatric-retinal-regeneration","status":"publish","type":"post","link":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/","title":{"rendered":"ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration"},"content":{"rendered":"<h2 class=\"wp-block-heading\">\u0645\u0642\u062f\u0645\u0629<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED&#8217;s ACE Retino\u2122 clinical trial represents a significant step toward changing that reality.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">About the ACE Retino\u2122 Trial<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-1024x768.png\" alt=\"\" class=\"wp-image-1059 lazyload\" style=\"width:456px;height:auto\"><noscript><img decoding=\"async\" width=\"1024\" height=\"768\" src=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-1024x768.png\" alt=\"\" class=\"wp-image-1059\" style=\"width:456px;height:auto\" srcset=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-1024x768.png 1024w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-300x225.png 300w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-768x576.png 768w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-16x12.png 16w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog-600x450.png 600w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog.png 1448w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/noscript><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">The ACE Retino\u2122 clinical trial (registered as NCT06787482 on ClinicalTrials.gov) is investigating the safety, tolerability, and preliminary efficacy of ACE Retino\u2122 \u2014 a Pico Cell Matrix-derived formulation \u2014 in paediatric patients with corneal opacity and associated retinal and\/or optic nerve involvement. This is the first in-human investigation of ACE Retino\u2122 in a paediatric ocular pathology setting.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The Technology: <a href=\"https:\/\/www.ace-cells.co.uk\/ace-cell-factor-deficiency-theory\" title=\"\">Pico Cell Matrix<\/a><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ACE Retino\u2122 is produced through BCRMED&#8217;s proprietary Pico Cell Matrix technology, which processes tissue-derived peptides into nanometer and picometer-scale bioactive particles. This process preserves a rich profile of retinal-specific growth factors, exosomal signals, neuroprotective peptides, and organotropic complexes that support the eye&#8217;s natural regenerative capacity. The ultra-small particle size is key \u2014 it enables these bioactive molecules to reach ocular tissues that are otherwise difficult to penetrate.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why This Trial Matters<\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-1024x768.png\" alt=\"\" class=\"wp-image-1061 lazyload\" style=\"width:499px;height:auto\"><noscript><img decoding=\"async\" width=\"1024\" height=\"768\" src=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-1024x768.png\" alt=\"\" class=\"wp-image-1061\" style=\"width:499px;height:auto\" srcset=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-1024x768.png 1024w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-300x225.png 300w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-768x576.png 768w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-16x12.png 16w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2-600x450.png 600w, http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog2.png 1448w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/noscript><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">Retinal degenerative diseases represent a major cause of irreversible vision impairment globally. Current clinical evidence shows that stem cell and regenerative approaches for retinal conditions have transitioned from preclinical investigation into early-phase trials with promising safety profiles. ACE Retino\u2122 offers a novel, non-surgical adjunctive pathway \u2014 potentially reducing the lifetime visual disability burden for affected children without requiring invasive procedures.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What the Trial Is Measuring<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The primary outcome measures include safety endpoints \u2014 adverse events and tolerability \u2014 alongside vision and retinal function parameters such as visual acuity, retinal imaging, and electrophysiology. Participants undergo serial assessments of ocular structure and function throughout the defined study period. The trial is conducted under Good Clinical Practice standards with full ethical oversight.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Who Can Participate<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The trial is open to children with documented corneal opacity and retinal or optic nerve involvement who meet the inclusion and exclusion criteria defined in the trial protocol. Parents and legal guardians are encouraged to review the full informed consent documentation on ClinicalTrials.gov (NCT06787482) or contact the BCRMED clinical team directly for further information.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">An Important Disclosure<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">ACE Retino\u2122 is currently under clinical investigation and is not yet approved for general treatment of retinal or corneal conditions. All participants and their guardians should carefully review the risks, benefits, and alternatives outlined in the consent documentation. The trial status may change; always refer to the clinical registry for the most current information.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The ACE Retino\u2122 trial reflects BCRMED&#8217;s commitment to rigorous, evidence-based advancement in regenerative ophthalmology. We believe that the children who cannot yet be helped by conventional medicine deserve access to the most promising emerging therapies \u2014 evaluated with full scientific and ethical rigour.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Call to Action: <\/strong>Read the full trial details at bcregmed.co.uk\/ace-retino-clinical-trial or visit ClinicalTrials.gov: <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06787482?term=ace%20retino&amp;viewType=Card&amp;rank=1\" title=\"\">NCT06787482<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED&#8217;s ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122 &#8230; <a title=\"ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration\" class=\"read-more\" href=\"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/\" aria-label=\"Read more about ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration\">\u0627\u0642\u0631\u0623 \u0627\u0644\u0645\u0632\u064a\u062f<\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[23],"tags":[31,32,27],"class_list":["post-1057","post","type-post","status-publish","format-standard","hentry","category-researches","tag-amd","tag-retinitis-pigmentosa","tag-stem-cells"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED&#039;s ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Dr. Alaa Abdelkarim\"\/>\n\t<meta name=\"google-site-verification\" content=\"KXhGAhGeneL3A_0XA0SIyua66_uwoltIj5b-9s4DpnQ\" \/>\n\t<link rel=\"canonical\" href=\"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"ar_AR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"BCRMED Global - Redefining Healing Through Regenerative Medicine\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global\" \/>\n\t\t<meta property=\"og:description\" content=\"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED&#039;s ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122\" \/>\n\t\t<meta property=\"og:url\" content=\"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/\" \/>\n\t\t<meta property=\"og:image\" content=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/01\/cropped-BCRMEDLOGOx-01-01.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-06-03T09:23:25+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-03T09:23:29+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61574857696587\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@bcrmed\" \/>\n\t\t<meta name=\"twitter:title\" content=\"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED&#039;s ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@bcrmed\" \/>\n\t\t<meta name=\"twitter:image\" content=\"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/01\/cropped-BCRMEDLOGOx-01-01.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#blogposting\",\"name\":\"ACE Retino\\u2122 Clinical Trial: BCRMED\\u2019s Landmark Study in Retinal Regeneration - BCRMED Global\",\"headline\":\"ACE Retino\\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration\",\"author\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/author\\\/dralaakarimgmail-com\\\/#author\"},\"publisher\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/bcregmed.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ace-retino-plog.png\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#articleImage\",\"width\":1448,\"height\":1086},\"datePublished\":\"2026-06-03T09:23:25+01:00\",\"dateModified\":\"2026-06-03T09:23:29+01:00\",\"inLanguage\":\"ar\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#webpage\"},\"isPartOf\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#webpage\"},\"articleSection\":\"Researches, AMD, Retinitis pigmentosa, stem cells\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/category\\\/researches\\\/#listItem\",\"name\":\"Researches\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/category\\\/researches\\\/#listItem\",\"position\":2,\"name\":\"Researches\",\"item\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/category\\\/researches\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#listItem\",\"name\":\"ACE Retino\\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#listItem\",\"position\":3,\"name\":\"ACE Retino\\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/category\\\/researches\\\/#listItem\",\"name\":\"Researches\"}}]},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#organization\",\"name\":\"British Centre for regenerative medicine\",\"description\":\"Redefining Healing Through Regenerative Medicine bcrmed, online_clinic, longevity, regerative\",\"url\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/\",\"telephone\":\"+447473922553\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/bcregmed.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-BCRMEDLOGOx-01-01.png\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#organizationLogo\",\"width\":1560,\"height\":964},\"image\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61574857696587\",\"https:\\\/\\\/x.com\\\/bcrmed\",\"https:\\\/\\\/www.instagram.com\\\/bcregmed\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@tlmezero\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/86389870\\\/admin\\\/page-posts\\\/published\\\/\"]},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/author\\\/dralaakarimgmail-com\\\/#author\",\"url\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/author\\\/dralaakarimgmail-com\\\/\",\"name\":\"Dr. Alaa Abdelkarim\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ba8ac04e4c051019600a45ff76aaa0381ec82894fdb2c750589fad8af8ca163f?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Dr. Alaa Abdelkarim\"}},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#webpage\",\"url\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/\",\"name\":\"ACE Retino\\u2122 Clinical Trial: BCRMED\\u2019s Landmark Study in Retinal Regeneration - BCRMED Global\",\"description\":\"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \\u2014 with many facing lifelong visual impairment or blindness. BCRMED's ACE Retino\\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\\u2122\",\"inLanguage\":\"ar\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#website\"},\"breadcrumb\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/ace-retino-clinical-trial-paediatric-retinal-regeneration\\\/#breadcrumblist\"},\"author\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/author\\\/dralaakarimgmail-com\\\/#author\"},\"creator\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/author\\\/dralaakarimgmail-com\\\/#author\"},\"datePublished\":\"2026-06-03T09:23:25+01:00\",\"dateModified\":\"2026-06-03T09:23:29+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#website\",\"url\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/\",\"name\":\"BCRMED\",\"description\":\"Redefining Healing Through Regenerative Medicine\",\"inLanguage\":\"ar\",\"publisher\":{\"@id\":\"http:\\\/\\\/bcregmed.co.uk\\\/ar\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global","description":"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED's ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122","canonical_url":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"KXhGAhGeneL3A_0XA0SIyua66_uwoltIj5b-9s4DpnQ","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#blogposting","name":"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global","headline":"ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration","author":{"@id":"http:\/\/bcregmed.co.uk\/ar\/author\/dralaakarimgmail-com\/#author"},"publisher":{"@id":"http:\/\/bcregmed.co.uk\/ar\/#organization"},"image":{"@type":"ImageObject","url":"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/06\/ace-retino-plog.png","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#articleImage","width":1448,"height":1086},"datePublished":"2026-06-03T09:23:25+01:00","dateModified":"2026-06-03T09:23:29+01:00","inLanguage":"ar","mainEntityOfPage":{"@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#webpage"},"isPartOf":{"@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#webpage"},"articleSection":"Researches, AMD, Retinitis pigmentosa, stem cells"},{"@type":"BreadcrumbList","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/#listItem","position":1,"name":"Home","item":"http:\/\/bcregmed.co.uk\/ar\/","nextItem":{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/category\/researches\/#listItem","name":"Researches"}},{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/category\/researches\/#listItem","position":2,"name":"Researches","item":"http:\/\/bcregmed.co.uk\/ar\/category\/researches\/","nextItem":{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#listItem","name":"ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration"},"previousItem":{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#listItem","position":3,"name":"ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration","previousItem":{"@type":"ListItem","@id":"http:\/\/bcregmed.co.uk\/ar\/category\/researches\/#listItem","name":"Researches"}}]},{"@type":"Organization","@id":"http:\/\/bcregmed.co.uk\/ar\/#organization","name":"British Centre for regenerative medicine","description":"Redefining Healing Through Regenerative Medicine bcrmed, online_clinic, longevity, regerative","url":"http:\/\/bcregmed.co.uk\/ar\/","telephone":"+447473922553","logo":{"@type":"ImageObject","url":"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/01\/cropped-BCRMEDLOGOx-01-01.png","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#organizationLogo","width":1560,"height":964},"image":{"@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61574857696587","https:\/\/x.com\/bcrmed","https:\/\/www.instagram.com\/bcregmed\/","https:\/\/www.tiktok.com\/@tlmezero","https:\/\/www.linkedin.com\/company\/86389870\/admin\/page-posts\/published\/"]},{"@type":"Person","@id":"http:\/\/bcregmed.co.uk\/ar\/author\/dralaakarimgmail-com\/#author","url":"http:\/\/bcregmed.co.uk\/ar\/author\/dralaakarimgmail-com\/","name":"Dr. Alaa Abdelkarim","image":{"@type":"ImageObject","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/ba8ac04e4c051019600a45ff76aaa0381ec82894fdb2c750589fad8af8ca163f?s=96&d=mm&r=g","width":96,"height":96,"caption":"Dr. Alaa Abdelkarim"}},{"@type":"WebPage","@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#webpage","url":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/","name":"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global","description":"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED's ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122","inLanguage":"ar","isPartOf":{"@id":"http:\/\/bcregmed.co.uk\/ar\/#website"},"breadcrumb":{"@id":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/#breadcrumblist"},"author":{"@id":"http:\/\/bcregmed.co.uk\/ar\/author\/dralaakarimgmail-com\/#author"},"creator":{"@id":"http:\/\/bcregmed.co.uk\/ar\/author\/dralaakarimgmail-com\/#author"},"datePublished":"2026-06-03T09:23:25+01:00","dateModified":"2026-06-03T09:23:29+01:00"},{"@type":"WebSite","@id":"http:\/\/bcregmed.co.uk\/ar\/#website","url":"http:\/\/bcregmed.co.uk\/ar\/","name":"BCRMED","description":"Redefining Healing Through Regenerative Medicine","inLanguage":"ar","publisher":{"@id":"http:\/\/bcregmed.co.uk\/ar\/#organization"}}]},"og:locale":"ar_AR","og:site_name":"BCRMED Global - Redefining Healing Through Regenerative Medicine","og:type":"article","og:title":"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global","og:description":"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED's ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122","og:url":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/","og:image":"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/01\/cropped-BCRMEDLOGOx-01-01.png","article:published_time":"2026-06-03T09:23:25+00:00","article:modified_time":"2026-06-03T09:23:29+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61574857696587","twitter:card":"summary_large_image","twitter:site":"@bcrmed","twitter:title":"ACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration - BCRMED Global","twitter:description":"Introduction Retinal degeneration and corneal opacities represent some of the most devastating conditions in paediatric ophthalmology. For children affected by these conditions, conventional medicine has historically offered limited options \u2014 with many facing lifelong visual impairment or blindness. BCRMED's ACE Retino\u2122 clinical trial represents a significant step toward changing that reality. About the ACE Retino\u2122","twitter:creator":"@bcrmed","twitter:image":"http:\/\/bcregmed.co.uk\/wp-content\/uploads\/2026\/01\/cropped-BCRMEDLOGOx-01-01.png"},"aioseo_meta_data":{"post_id":"1057","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-06-03 09:23:29","updated":"2026-06-03 09:47:47","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"http:\/\/bcregmed.co.uk\/ar\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"http:\/\/bcregmed.co.uk\/ar\/category\/researches\/\" title=\"Researches\">Researches<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tACE Retino\u2122 Clinical Trial: BCRMED\u2019s Landmark Study in Retinal Regeneration\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"http:\/\/bcregmed.co.uk\/ar\/"},{"label":"Researches","link":"http:\/\/bcregmed.co.uk\/ar\/category\/researches\/"},{"label":"ACE Retino\u2122 Clinical Trial: BCRMED&#8217;s Landmark Study in Retinal Regeneration","link":"http:\/\/bcregmed.co.uk\/ar\/ace-retino-clinical-trial-paediatric-retinal-regeneration\/"}],"_links":{"self":[{"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/posts\/1057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/comments?post=1057"}],"version-history":[{"count":1,"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/posts\/1057\/revisions"}],"predecessor-version":[{"id":1062,"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/posts\/1057\/revisions\/1062"}],"wp:attachment":[{"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/media?parent=1057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/categories?post=1057"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/bcregmed.co.uk\/ar\/wp-json\/wp\/v2\/tags?post=1057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}